$AMPE new volume upturn $4.40
NYSE
Website
88 % Buy
detailed opinion
Shares Outstanding: 51.97M
Float: 38.68M
% Held by Insiders: 10.95%
% Held by Institutions: 30.90%
Shares Short (as of Dec 31, 2014): 9.57M
Short Ratio (as of Dec 31, 2014): 22.80
Short % of Float (as of Dec 31, 2014): 19.80%
Shares Short (prior month): 9.88M
10-Q 11/7/14
Summary
Recent Trades
Headlines
Thursday, January 22, 2015
Luoxis Establishes Initial European Distribution Network for RedoxSYS™ Diagnostic SystemPR Newswire (Thu, Jan 22)
Thursday, January 15, 2015
Ampio Pharmaceuticals (AMPE) in Focus: Stock Surges 14.1% - Tale of the TapeZacks (Thu, Jan 15)
Thursday, January 8, 2015
Vyrix Pharmaceuticals to Present at Biotech Showcase™ 2015PR Newswire (Thu, Jan
Tuesday, January 6, 2015
Luoxis to Present at Biotech Showcase 2015PR Newswire (Tue, Jan 6)
Monday, December 29, 2014
AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PrEDGAR Online (Mon, Dec 29)
Thursday, December 4, 2014
Ampio Pharmaceuticals to present at the Oppenheimer Annual Healthcare Conference on December 11th, 2014PR Newswire (Thu, Dec 4)
Monday, December 1, 2014
Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (STRUT) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twenty of the TrialPR Newswire (Mon, Dec 1)
Monday, November 24, 2014
Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative StressPR Newswire (Mon, Nov 24)
Saturday, November 15, 2014
AMPIO PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials (Sat, Nov 15)
Wednesday, November 12, 2014
Exclusive photos of Ampio Pharmaceuticals mining for positive results from its Ampion knee arthritis study .Yahoo Finance Contributors (Wed, Nov 12)
Ampio updates status of clinical trials and manufacturing facilityPR Newswire (Wed, Nov 12)
Tuesday, November 11, 2014
Ampio posts 3Q lossAP (Tue, Nov 11)
Monday, November 10, 2014
10-Q for Ampio Pharmaceuticals, Inc.Company Spotlight (Mon, Nov 10)
Friday, November 7, 2014
AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, Nov 7)
Tuesday, October 21, 2014
AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and ExhiEDGAR Online (Tue, Oct 21)
Monday, October 20, 2014
Will Ampio (AMPE) Continue to Surge Higher?Zacks (Mon, Oct 20)
Luoxis to Highlight RedoxSYS at Two Upcoming Scientific ConferencesPR Newswire (Mon, Oct 20)
Friday, October 17, 2014
Ironwood/Actavis Move Linzess into Phase II Study for OICZacks (Fri, Oct 17)
Tetraphase (TTPH) Crumbles: Stock Tanks by 15%Zacks (Fri, Oct 17)
Thursday, October 16, 2014
Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (MI) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twelve of the TrialPR Newswire (Thu, Oct 16)
NYSE
Website
88 % Buy
detailed opinion
Shares Outstanding: 51.97M
Float: 38.68M
% Held by Insiders: 10.95%
% Held by Institutions: 30.90%
Shares Short (as of Dec 31, 2014): 9.57M
Short Ratio (as of Dec 31, 2014): 22.80
Short % of Float (as of Dec 31, 2014): 19.80%
Shares Short (prior month): 9.88M
10-Q 11/7/14
Summary
Recent Trades
Headlines
Thursday, January 22, 2015
Luoxis Establishes Initial European Distribution Network for RedoxSYS™ Diagnostic SystemPR Newswire (Thu, Jan 22)
Thursday, January 15, 2015
Ampio Pharmaceuticals (AMPE) in Focus: Stock Surges 14.1% - Tale of the TapeZacks (Thu, Jan 15)
Thursday, January 8, 2015
Vyrix Pharmaceuticals to Present at Biotech Showcase™ 2015PR Newswire (Thu, Jan
Tuesday, January 6, 2015
Luoxis to Present at Biotech Showcase 2015PR Newswire (Tue, Jan 6)
Monday, December 29, 2014
AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PrEDGAR Online (Mon, Dec 29)
Thursday, December 4, 2014
Ampio Pharmaceuticals to present at the Oppenheimer Annual Healthcare Conference on December 11th, 2014PR Newswire (Thu, Dec 4)
Monday, December 1, 2014
Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (STRUT) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twenty of the TrialPR Newswire (Mon, Dec 1)
Monday, November 24, 2014
Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative StressPR Newswire (Mon, Nov 24)
Saturday, November 15, 2014
AMPIO PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials (Sat, Nov 15)
Wednesday, November 12, 2014
Exclusive photos of Ampio Pharmaceuticals mining for positive results from its Ampion knee arthritis study .Yahoo Finance Contributors (Wed, Nov 12)
Ampio updates status of clinical trials and manufacturing facilityPR Newswire (Wed, Nov 12)
Tuesday, November 11, 2014
Ampio posts 3Q lossAP (Tue, Nov 11)
Monday, November 10, 2014
10-Q for Ampio Pharmaceuticals, Inc.Company Spotlight (Mon, Nov 10)
Friday, November 7, 2014
AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, Nov 7)
Tuesday, October 21, 2014
AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and ExhiEDGAR Online (Tue, Oct 21)
Monday, October 20, 2014
Will Ampio (AMPE) Continue to Surge Higher?Zacks (Mon, Oct 20)
Luoxis to Highlight RedoxSYS at Two Upcoming Scientific ConferencesPR Newswire (Mon, Oct 20)
Friday, October 17, 2014
Ironwood/Actavis Move Linzess into Phase II Study for OICZacks (Fri, Oct 17)
Tetraphase (TTPH) Crumbles: Stock Tanks by 15%Zacks (Fri, Oct 17)
Thursday, October 16, 2014
Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (MI) Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Twelve of the TrialPR Newswire (Thu, Oct 16)
